| 发明名称 |
A pharmaceutical composition containing ezrin mutated on tyrosine 353 |
| 摘要 |
The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors. |
| 申请公布号 |
AU3600199(A) |
申请公布日期 |
1999.10.11 |
| 申请号 |
AU19990036001 |
申请日期 |
1999.03.18 |
| 申请人 |
INSTITUT CURIE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) |
发明人 |
MONIQUE ARPIN;TIZIANA CREPALDI;ALEXIS GAUTREAU;DANIEL LOUVARD |
| 分类号 |
A61K38/17;A61K48/00 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
